2 unknown, 1 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Completed 1, Terminated 1 |
Follow Aposense Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation [18F]-ML-10 in conjunction with PET imaging - Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms | Phase 2 | Unknown | Aposense Ltd. | 60 | 2010-12-01 | 2010-12-17 |
| Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy. 2-(5-fluoro-pentyl)-2-methyl-malonic-acid ([18F]-ML-10), Stereotactic Radio-Surgery (SRS) therapy, Positron Emission Tomography - Brain Metastases, Solid Tumors | Phase 2 | Unknown | Aposense Ltd. | 30 | 2008-11-01 | 2010-05-12 |
| 18F ML-10 for Early Detection of Response of Brain Metastases to SRS ([18F]-ML-10) - Metastasis to Brain of Unknown Primary | Phase 2 | Terminated | Aposense Ltd. | 1 | 2008-07-01 | 2013-02-15 |
| 18F ML-10 for Early Detection of Response of Brain Metastases to WBRT 18F ML-10 - Solid Tumors, Brain Metastases | Phase 2 | Completed | Aposense Ltd. | 10 | 2008-03-01 | 2013-02-13 |
Brain Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (1) · Head and Neck Neoplasms (1)
5-fluoropentyl-2-methylmalonic acid (4) · Magnetic Resonance Spectroscopy (2) · Spermine Synthase (1) · Therapeutics (1)
United States (2)
Aaron Allen, M.D. (1) · Aaron Allen, MD (1) · David Sher, MD, MPH (1) · Heron Dwight, MD (1) · Yael Cohen (1)